2024
Trends and regional differences for fertility preservation procedures in women with breast cancer
Turan V, Bedoschi G, Lee D, Barbosa C, de Oliveira R, Sacinti K, Sonmezer M, Lambertini M, Massarotti C, Schaub A, Wang E, Gayete-Lafuente S, Dunlop C, Anderson R, Bang H, Oktay K. Trends and regional differences for fertility preservation procedures in women with breast cancer. Clinical Breast Cancer 2024 PMID: 39428290, DOI: 10.1016/j.clbc.2024.09.011.Peer-Reviewed Original ResearchWomen of reproductive ageFertility preservationBreast cancerTissue cryopreservationYoung womenReproductive ageOvarian tissue cryopreservationFertility preservation methodsNormal ovarian functionOvarian stimulation cyclesFertility preservation proceduresFertility preservation practicesDiagnosed breast cancerOocyte cryopreservationOvarian stimulationTertiary centerMulticenter studyOvarian functionStimulated cyclesParticipating centersRegional time trendsBreastCancerPreservation proceduresChemotherapyUtility and Outcomes of Ovarian Tissue Cryopreservation and Transplantation for Gynecologic Cancers
Erden M, Gayete-Lafuente S, Vural N, Oktay K. Utility and Outcomes of Ovarian Tissue Cryopreservation and Transplantation for Gynecologic Cancers. Obstetrics And Gynecology 2024, 144: 481-492. PMID: 39173181, PMCID: PMC11499045, DOI: 10.1097/aog.0000000000005708.Peer-Reviewed Original ResearchCryopreserved ovarian tissue transplantationOvarian tissue cryopreservationOvarian tissue transplantationTissue cryopreservationAutologous transplantationGynecologic cancerTissue transplantationOutcome of autologous transplantationPreserving ovarian functionCochrane Library databasesOvarian endocrine functionPooled-effect estimatesSystematic reviewRisk-of-bias assessmentOvarian stimulationHematologic malignanciesLonger-term outcomesFertility preservationOvarian functionBreast cancerLibrary databasesTransplantationGraft longevityCancerEndocrine function
2022
PRESENCE OF BRCA MUTATIONS AND A PRE-CHEMOTHERAPY AMH LEVEL OF < 2ng/ML STRONGLY PREDICT RISK OF AMENORRHEA IN WOMEN WITH BREAST CANCER
Oktay K, Turan V, Bedoschi G, Goldfarb S, Bang H. PRESENCE OF BRCA MUTATIONS AND A PRE-CHEMOTHERAPY AMH LEVEL OF < 2ng/ML STRONGLY PREDICT RISK OF AMENORRHEA IN WOMEN WITH BREAST CANCER. Fertility And Sterility 2022, 118: e231. DOI: 10.1016/j.fertnstert.2022.08.652.Peer-Reviewed Original Research
2020
Impact of adjuvant chemotherapy or tamoxifen-alone on the ovarian reserve of young women with breast cancer
Goldfarb S, Turan V, Bedoschi G, Taylan E, Abdo N, Cigler T, Bang H, Patil S, Dickler M, Oktay K. Impact of adjuvant chemotherapy or tamoxifen-alone on the ovarian reserve of young women with breast cancer. Breast Cancer Research And Treatment 2020, 185: 165-173. PMID: 32930927, PMCID: PMC7877450, DOI: 10.1007/s10549-020-05933-7.Peer-Reviewed Original ResearchConceptsAnti-Mullerian hormoneOvarian reserveAdjuvant chemotherapyBreast cancerAMH levelsChemotherapy regimensCompletion of ACSerum AMH levelsAdjuvant tamoxifenAMH recoveryChemotherapy groupPrimary diagnosisBaseline ageMethodsOne hundredAMH assessmentRegimensChemotherapyYoung womenTamoxifenSignificant recoveryCancerMixed effects modelsMonthsTreatment effectsWomenIMPACT OF ADJUVANT CHEMOTHERAPY OR TAMOXIFEN ALONE ON THE OVARIAN RESERVE OF YOUNG WOMEN WITH BREAST CANCER: A PROSPECTIVE LONGITUDINAL STUDY
Oktay K, Turan V, Bedoschi G, Taylan E, Bang H, Dickler M, Goldfarb S. IMPACT OF ADJUVANT CHEMOTHERAPY OR TAMOXIFEN ALONE ON THE OVARIAN RESERVE OF YOUNG WOMEN WITH BREAST CANCER: A PROSPECTIVE LONGITUDINAL STUDY. Fertility And Sterility 2020, 114: e531-e532. DOI: 10.1016/j.fertnstert.2020.09.051.Peer-Reviewed Original ResearchExpert Commentary on Fertility Preservation in Colorectal Cancers: Current State and Practical Tips for the Cancer Practitioner.
Oktay K. Expert Commentary on Fertility Preservation in Colorectal Cancers: Current State and Practical Tips for the Cancer Practitioner. Diseases Of The Colon & Rectum 2020, 63: 726-727. PMID: 32384403, DOI: 10.1097/dcr.0000000000001688.Peer-Reviewed Original Research
2019
Ovarian Stimulation in Women with Breast Cancer
Turan V, Oktay K. Ovarian Stimulation in Women with Breast Cancer. 2019, 105-115. DOI: 10.1007/978-3-030-24086-8_10.Peer-Reviewed Original ResearchFertility preservation optionsOvarian stimulationBreast cancerPreservation optionsEffective fertility preservation optionsEstrogen-sensitive malignanciesReproductive-aged womenCommon cancer typesCytotoxic chemotherapyGonadal failureAged womenOocyte cryopreservationNumber of womenCancer typesCancerWomenStimulationTreatmentHigh levelsChemotherapyPatientsMalignancyOptionsRadiotherapyEstradiolFertility preservation in gynecologic cancers
Taylan E, Oktay K. Fertility preservation in gynecologic cancers. Gynecologic Oncology 2019, 155: 522-529. PMID: 31604663, DOI: 10.1016/j.ygyno.2019.09.012.Peer-Reviewed Original ResearchConceptsFertility preservationGynecologic cancerFertility-sparing surgical approachCancer survivorship careReproductive-age womenGynecologic malignanciesSurvivorship careSurgical approachTreatment optionsAge womenOvarian cancerNumber of womenCancerWomenReproductive technologiesSignificant proportionCurrent knowledgeReview articleMalignancyReproductive potentialCare
2018
Ovarian Stimulation and the Long-Term Risk of Cancer
Taylan E, Oktay K. Ovarian Stimulation and the Long-Term Risk of Cancer. 2018, 344-348. DOI: 10.1016/b978-0-12-801238-3.64898-5.Peer-Reviewed Original Research
2016
Embryo Cryopreservation in Breast Cancer Patients
Bedoschi G, Oktay K. Embryo Cryopreservation in Breast Cancer Patients. 2016, 39-52. DOI: 10.1007/978-4-431-55963-4_3.Peer-Reviewed Original ResearchBreast cancer patientsCancer patientsFertility preservationEmbryo cryopreservationAdjuvant systemic chemotherapyFertility preservation techniquesOvarian stimulation protocolsBreast cancer casesOvarian stimulationSystemic chemotherapyOvarian reserveIncident casesAromatase inhibitorsBreast cancerCancer casesStimulation protocolPatientsDonor semenCommon typeWomenFuture reproductive potentialCancerPreservation techniquesAttractive strategySpecial consideration
2015
Comparison of random start controlled ovarian stimulation with standard start in letrozole gonadotropin cycles for fertility preservation in women with breast cancer
Bedoschi G, Turan V, Emirdar V, Sonmezer M, Oktay K. Comparison of random start controlled ovarian stimulation with standard start in letrozole gonadotropin cycles for fertility preservation in women with breast cancer. Fertility And Sterility 2015, 104: e267. DOI: 10.1016/j.fertnstert.2015.07.838.Peer-Reviewed Original ResearchLong-term safety of fertility preservation by ovarian stimulation and concurrent aromatase inhibitor treatment in women with breast cancer.
Oktay K, Turan V, Kim J. Long-term safety of fertility preservation by ovarian stimulation and concurrent aromatase inhibitor treatment in women with breast cancer. Journal Of Clinical Oncology 2015, 33: 9521-9521. DOI: 10.1200/jco.2015.33.15_suppl.9521.Peer-Reviewed Original ResearchOvarian Tissue Cryopreservation: Where Are We Now?
Bedoschi G, Oktay K. Ovarian Tissue Cryopreservation: Where Are We Now? 2015, 71-78. DOI: 10.1007/978-3-319-17849-3_6.Peer-Reviewed Original ResearchFertility preservationOvarian stimulationOvarian cortical piecesAdvanced treatment strategiesPre-pubertal childrenOvarian cryopreservationCortical piecesSurvival outcomesOvarian functionCancer careCancer patientsTreatment strategiesEndocrine functionOocyte cryopreservationAccelerated phaseEarly detectionCancer communityPatientsTransplantationFirst descriptionStimulationSufficient time periodChemotherapySuccessful restorationCancer
2014
Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropin in patients with breast cancer: a prospective controlled study with subgroup analysis
Kim J, Turan V, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropin in patients with breast cancer: a prospective controlled study with subgroup analysis. Fertility And Sterility 2014, 102: e32. DOI: 10.1016/j.fertnstert.2014.07.118.Peer-Reviewed Original Research
2013
The impact of long-term tamoxifen treatment on ovarian reserve markers in women with breast cancer: a prospective-longitudinal study
Oktay K, Bedoschi G, Dickler M, Goldfarb S, Turan V, Moy F. The impact of long-term tamoxifen treatment on ovarian reserve markers in women with breast cancer: a prospective-longitudinal study. Fertility And Sterility 2013, 100: s64. DOI: 10.1016/j.fertnstert.2013.07.1879.Peer-Reviewed Original ResearchSafety and feasibility of performing two consecutive Letrozole-FSH stimulation cycles for fertility preservation in women with breast cancer
Bedoschi G, Turan V, Oktay K. Safety and feasibility of performing two consecutive Letrozole-FSH stimulation cycles for fertility preservation in women with breast cancer. Fertility And Sterility 2013, 100: s65. DOI: 10.1016/j.fertnstert.2013.07.1883.Peer-Reviewed Original ResearchFertility preservation in the female with cancer
Rodriguez-Wallberg K, Oktay K. Fertility preservation in the female with cancer. 2013, 273-281. DOI: 10.1017/cbo9780511997761.031.Peer-Reviewed Original ResearchFertility preservationMale cancer patientsFertility preservation strategiesImpact of cancerPost-treatment managementHormone therapySuch patientsCancer patientsNursing staffArtificial reproductive technologiesReproductive endocrinologyTesticular tissueReproductive medicineCancerReproductive technologiesPatientsMale fertilityCliniciansMenCryopreservation of spermChemotherapyPreservation strategiesSurgeryOncologistsTherapy
2012
Evaluation of ovarian and testicular tissue cryopreservation and their bundling with medically-indicated procedures in children undergoing gonadotoxic therapies for blood dyscrasias or cancer
Babayev S, Karsy M, Arslan E, Kogan S, Oktay K. Evaluation of ovarian and testicular tissue cryopreservation and their bundling with medically-indicated procedures in children undergoing gonadotoxic therapies for blood dyscrasias or cancer. Fertility And Sterility 2012, 98: s36. DOI: 10.1016/j.fertnstert.2012.07.132.Peer-Reviewed Original ResearchThe Patient with a History of Estrogen‐Receptor Positive Cancer
Sönmezer M, Oktay K. The Patient with a History of Estrogen‐Receptor Positive Cancer. 2012, 205-207. DOI: 10.1002/9781444398854.ch49.Peer-Reviewed Original Research
2011
Approach to Fertility Preservation in Adult and Prepubertal Females
Rodriguez-Wallberg K, Oktay K. Approach to Fertility Preservation in Adult and Prepubertal Females. 2011, 233-241. DOI: 10.1007/978-1-4419-1783-6_18.Peer-Reviewed Original ResearchFertility preservationFemale patientsCancer treatmentFemale cancer survivorsAdult female patientsClinical presentationGonadotoxic treatmentCancer survivorsPrepubertal girlsPsychosocial distressPrepubertal femalesPatientsOvarian tissueMost cancersAvailable evidenceInfertilityMain diseaseTreatmentCancerWestern countriesAgeOnly optionOptionsIncidenceDisease